Code |
Title |
–
|
Top Categories
|
3 |
Administration
|
3E |
Physiological Systems and Anatomical Regions
|
3E0
|
Introduction
Administration, Physiological Systems and Anatomical Regions, Introduction
|
3E05 |
Peripheral Artery
|
3E053 |
Percutaneous
|
3E0530 |
Antineoplastic
|
3E05302
|
High-dose Interleukin-2
Introduction of High-dose Interleukin-2 into Peripheral Artery, Percutaneous Approach
|
3E05303
|
Low-dose Interleukin-2
Introduction of Low-dose Interleukin-2 into Peripheral Artery, Percutaneous Approach
|
3E05305
|
Other Antineoplastic
Introduction of Other Antineoplastic into Peripheral Artery, Percutaneous Approach
|
3E0530M
|
Monoclonal Antibody
Introduction of Antineoplastic, Monoclonal Antibody, into Peripheral Artery, Percutaneous Approach
|
3E0530P
|
Clofarabine
Introduction of Clofarabine into Peripheral Artery, Percutaneous Approach
|
3E0531 |
Thrombolytic
|
3E05316
|
Recombinant Human-activated Protein C
Introduction of Recombinant Human-activated Protein C into Peripheral Artery, Percutaneous
|
3E05317
|
Other Thrombolytic
Introduction of Other Thrombolytic into Peripheral Artery, Percutaneous Approach
|
3E0532 |
Anti-infective
|
3E05328
|
Oxazolidinones
Introduction of Oxazolidinones into Peripheral Artery, Percutaneous Approach
|
3E05329
|
Other Anti-infective
Introduction of Other Anti-infective into Peripheral Artery, Percutaneous Approach
|
3E0533 |
Anti-inflammatory
|
3E0533Z
|
No Qualifier
Introduction of Anti-inflammatory into Peripheral Artery, Percutaneous Approach
|
3E0534 |
Serum, Toxoid and Vaccine
|
3E0534Z
|
No Qualifier
Introduction of Serum, Toxoid and Vaccine into Peripheral Artery, Percutaneous Approach
|
3E0536 |
Nutritional Substance
|
3E0536Z
|
No Qualifier
Introduction of Nutritional Substance into Peripheral Artery, Percutaneous Approach
|
3E0537 |
Electrolytic and Water Balance Substance
|
3E0537Z
|
No Qualifier
Introduction of Electrolytic and Water Balance Substance into Peripheral Artery, Percutaneous Approach
|
3E053F |
Intracirculatory Anesthetic
|
3E053FZ
|
No Qualifier
Introduction of Intracirculatory Anesthetic into Peripheral Artery, Percutaneous Approach
|
3E053G |
Other Therapeutic Substance
|
3E053GC
|
Other Substance
Introduction of Other Therapeutic Substance into Peripheral Artery, Percutaneous Approach
|
3E053GN
|
Blood Brain Barrier Disruption
Introduction of Blood Brain Barrier Disruption Substance into Peripheral Artery, Percutaneous Approach
|
3E053H |
Radioactive Substance
|
3E053HZ
|
No Qualifier
Introduction of Radioactive Substance into Peripheral Artery, Percutaneous Approach
|
3E053K |
Other Diagnostic Substance
|
3E053KZ
|
No Qualifier
Introduction of Other Diagnostic Substance into Peripheral Artery, Percutaneous Approach
|
3E053N |
Analgesics, Hypnotics, Sedatives
|
3E053NZ
|
No Qualifier
Introduction of Analgesics, Hypnotics, Sedatives into Peripheral Artery, Percutaneous Approach
|
3E053P |
Platelet Inhibitor
|
3E053PZ
|
No Qualifier
Introduction of Platelet Inhibitor into Peripheral Artery, Percutaneous Approach
|
3E053R |
Antiarrhythmic
|
3E053RZ
|
No Qualifier
Introduction of Antiarrhythmic into Peripheral Artery, Percutaneous Approach
|
3E053T |
Destructive Agent
|
3E053TZ
|
No Qualifier
Introduction of Destructive Agent into Peripheral Artery, Percutaneous Approach
|
3E053V |
Hormone
|
3E053VG
|
Insulin
Introduction of Insulin into Peripheral Artery, Percutaneous Approach
|
3E053VH
|
Human B-type Natriuretic Peptide
Introduction of Human B-type Natriuretic Peptide into Peripheral Artery, Percutaneous Approach
|
3E053VJ
|
Other Hormone
Introduction of Other Hormone into Peripheral Artery, Percutaneous Approach
|
3E053W |
Immunotherapeutic
|
3E053WK
|
Immunostimulator
Introduction of Immunostimulator into Peripheral Artery, Percutaneous
|
3E053WL
|
Immunosuppressive
Introduction of Immunosuppressive into Peripheral Artery, Percutaneous
|
3E053X |
Vasopressor
|
3E053XZ
|
No Qualifier
Introduction of Vasopressor into Peripheral Artery, Percutaneous Approach
|